Pulmonary Disease · Hialeah, FL
NPI
1538156328
Since 2005
Specialty
Pulmonary Disease
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
7100 W 20th Ave, Suite 402
Hialeah, FL, 33016
Phone (305) 557-9552
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
349 services
Medicare patients, 2024
131
Average age 76
Drug cost, 2024
$2.2M
6,699 prescriptions
Company payments, 2025
$367
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fernando L Martinez Catinchi was code 99214 (office e&m - established), 244 times for 114 patients. In total Fernando L Martinez Catinchi billed 349 services in 3 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 244 | 114 | $103.66 | $25K |
| 94010 Pulmonary Function Testing | Office | 76 | 72 | $22.27 | $1,692 |
| 99204 Office E&M - New | Office | 29 | 29 | $133.56 | $3,873 |
By year: 2022 $47K for 526 services; 2023 $33K for 360 services; 2024 $31K for 349 services.
Medicare prescription drug claims, 2024
In 2024, the drug Fernando L Martinez Catinchi prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 2,264 prescriptions and refills. In total Fernando L Martinez Catinchi wrote 6,699 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 2,264 | 2,368 | 708 | $1.5M |
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,214 | 1,349 | 403 | $34K |
| Prednisone Generic | 633 | 678 | 412 | $1,022 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 370 | 392 | 108 | $247K |
| Ventolin Hfa Albuterol Sulfate | 360 | 372 | 137 | $19K |
| Fluticasone Propionate Generic | 293 | 425 | 120 | $3,319 |
| Breo Ellipta Fluticasone/Vilanterol | 249 | 258 | 70 | $101K |
| Azithromycin Generic | 217 | 217 | 173 | $955 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 122 | 122 | 102 | $835 |
| Symbicort Budesonide/Formoterol Fumarate | 116 | 120 | 44 | $28K |
| Mounjaro Tirzepatide | 114 | 116 | 24 | $122K |
| Ipratropium Bromide Generic | 109 | 124 | 62 | $2,366 |
| Montelukast Sodium Generic | 67 | 123 | 27 | $294 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 51 | 51 | 23 | $8,860 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 42 | 48 | 19 | $1,863 |
Brand drugs: 4,768 claims; generic drugs: - claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fernando L Martinez Catinchi $367 ($367 in general payments such as food, travel and fees) from 2 companies. The largest payer was GlaxoSmithKline, LLC. with $248.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.